Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions

International Journal of Cancer

Volumn 66, Issue 5, 1996, Pages 607-610

  Dummer, Wolfgang ^a   Bastian, Boris C ^a   Ernst, Norman ^a   Schänzle, Christoph ^a   Schwaaf, Antonius ^a   Bröcker, Eva Bettina ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 10; MONOCLONAL ANTIBODY HMB 45; TUMOR ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTIC NEVUS; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; SKIN BIOPSY;

BASE SEQUENCE; BIOPSY; HUMANS; INTERLEUKIN-10; MELANOMA; MOLECULAR SEQUENCE DATA; NEVUS; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029888382     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960529)66:5<607::AID-IJC4>3.0.CO;2-X     Document Type: Article

References (20)

1. BACCHETTA, R., BIGLER, M., TOURAINE, J.L., PARKMAN, P.A., TOVO, J., ABRAMS, R., DEWAAL MALEFYT, R. and RONCAROLO, M.G., High levels of IL-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA-mismatched hematopoietic stem cells. J. exp. Med., 179, 493-502 (1994).
2. BECKER, J.C., CZERNY, C. and BRÖCKER, E.B., Maintenance of clonal anergy by endogeously produced IL-10. Int. J. Immunol., 6, 1605-1612 (1994).
3. BLAY, J., BURDIN, N., ROUSSET, F., LENOIR, G., BIRON, P., PHILIP, T., BANCHEREAU, J. and FAVROT, M., Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood. 82, 2169-2174 (1993).
4. CHEN, Q., DANIEL, V., MAHER, D. and HERSEY, P., Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer, 56, 755-760 (1994).
5. DEWAAL MALEFYT, R., HAANEN, J., SPITS, H., RONCAROLO, M., TEVELDE, A., FIGDOR, C., JOHNSON, K., KASTELEIN, R., YSSEL, H. and DEVRIEW, J., Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class-II-major-histocompatibility-complex expression. J. exp. Med., 174, 915-924 (1991).
6. + T-cell clones and resting T cells. J. Immunol., 150, 4754-4765 (1993).
7. DING, L., LINSLEY, P., HUANG, L.Y., GERMAIN, R. and SHEVACH, E., IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol., 151, 1224-1234 (1993).
8. DUMMER, W., BECKER, J.C., SCHWAAF, A., LEVERKUS, M., MOLL, T. and BRÖCKER, E.B., Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Res. 5, 67-68 (1995).
9. FIORENTINO, D.F., BOND, M.W. and MOSMANN, T.R., Two types of mouse T-helper cells. IV. Th 2 clones secrete a factor that inhibits cytokine production by Th 1 clones. J. exp. Med., 170, 2081-2095 (1989).
10. GASTL, G.A., ABRAMS, J.S., NANUS, D.M , OSTERKAMP, R., SILVER, J., LIU, F., CHEN, M., ALBINO, A.P. and BANDER, N., Interleukin-10 production by human carcinoma cell lines and its relationship to interieukin-6 expression. Int. J. Cancer, 55, 96-101 (1993).
11. KHARKEVITCH, D., SEITO, D., BALCH, G.C., MEADA, T., BALCH, C.M. and ITOH, K., Characterization of autologous tumor-specific T-helper-2 cells in tumour-infiltrating lymphocytes from a patient with metastatic malignant melanoma. Int. J. Cancer, 58, 317-323 (1994).
12. KRÜGER-KRASAGAKES, S., KRASAGAKIS, K., GARBE, C., SCHMITT, E., HULS, C., BLANKENSTEIN, T. and DIAMANTSTEIN, T., Expression of interleukin-10 in human melanoma. Brit. J. Cancer, 70, 1182-1185 (1994).
13. LATTIME, E., MASTRANGELO, M., BAGASRA, O., LI, W. and BERD, D., Expression of cytokine mRNA in human melanoma tissues. Cancer. Immunol. Immunotherap., 41, 151-156 (1995).
14. MARCHANT, A., DEVIERE, J., BYL, B., DEGROOTE, D., VINCENT, J. and GOLDMAN, M., Interleukin-10 production during septicemia. Lancet, 343, 707-708 (1994).
15. MERVILLE, P., ROUSSET, F., BANCHEREAU, J., KLEIN, B. and BATAILLE, R., Serum interleukin-10 in early-stage multiple myeloma. Lancet, 340, 1544-1545 (1992).
16. OHMEN, J., HANIFIN, M., NICKOLOFF, B., REA, T., WYZYKOWSKI, R., KIM, J., JULLIEN, D., MCHUGH, T., NASIF, A., CHAN, S. and MODLIN, R., Over-expression of IL-10 in atopic dermatitis. J. Immunol , 154, 1956-1963 (1995).
17. PISA, P., HALAPI, E., PISA, E.K., GERDIN, E., HISING, C., BUCHT, A., GERDIN, B. and KIESLING, R., Selective expression of IL-10, interferon-γ and granulocyte-macrophage-colony-stimulating factor in ovarian-cancer biopsies. Proc. nat. Acad. Sci. (Wash.), 89, 7708-7712 (1992).
18. ROSENBERG, S.A., Immunotherapy and gene therapy of cancer. Cancer Res., 51 (Suppl.), 5074-5079 (1991).
19. RUNGER, T.M., KLEIN, C.E., BECKER, J.C. and BRÖCKER, E.B., The role of genetic instability adhesion-cell motility and immune escape mechanisms in melanoma progression. Curr. Opin. Oncol., 6, 188-196 (1994).
20. TOPALIAN, S.L., SOLOMON, D. and ROSENBERG, S.A., Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol., 142, 3714-3725 (1989).